loading
Schlusskurs vom Vortag:
$5.12
Offen:
$5.56
24-Stunden-Volumen:
1.15M
Relative Volume:
3.76
Marktkapitalisierung:
$63.68M
Einnahmen:
$5.12M
Nettoeinkommen (Verlust:
$-67.00M
KGV:
-4.5646
EPS:
-1.47
Netto-Cashflow:
$-38.94M
1W Leistung:
+49.78%
1M Leistung:
+74.29%
6M Leistung:
+9.69%
1J Leistung:
-39.55%
1-Tages-Spanne:
Value
$5.50
$6.79
1-Wochen-Bereich:
Value
$3.90
$6.79
52-Wochen-Spanne:
Value
$3.28
$13.60

Verrica Pharmaceuticals Inc Stock (VRCA) Company Profile

Name
Firmenname
Verrica Pharmaceuticals Inc
Name
Telefon
484-453-3300
Name
Adresse
10 NORTH HIGH STREET, WEST CHESTER, PA
Name
Mitarbeiter
71
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-11
Name
Neueste SEC-Einreichungen
Name
VRCA's Discussions on Twitter

Vergleichen Sie VRCA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
VRCA
Verrica Pharmaceuticals Inc
6.71 48.59M 5.12M -67.00M -38.94M -1.47
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
432.17 109.05B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
784.61 82.75B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
445.12 56.78B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
917.63 56.52B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
204.51 44.58B 447.02M -1.18B -906.14M -6.1812

Verrica Pharmaceuticals Inc Stock (VRCA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-11-06 Herabstufung H.C. Wainwright Buy → Neutral
2024-11-05 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2023-07-25 Hochstufung Needham Hold → Buy
2023-03-22 Eingeleitet Jefferies Buy
2023-02-13 Hochstufung RBC Capital Mkts Sector Perform → Outperform
2022-05-25 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2021-05-14 Eingeleitet RBC Capital Mkts Outperform
2020-12-24 Bestätigt H.C. Wainwright Buy
2020-07-15 Herabstufung BofA Securities Buy → Neutral
2020-06-30 Bestätigt H.C. Wainwright Buy
2020-06-24 Eingeleitet Northland Capital Outperform
2020-03-24 Eingeleitet Needham Buy
2019-02-21 Eingeleitet H.C. Wainwright Buy
Alle ansehen

Verrica Pharmaceuticals Inc Aktie (VRCA) Neueste Nachrichten

pulisher
Nov 26, 2025

Insider Stock Purchases: November 26, 2025 - Quiver Quantitative

Nov 26, 2025
pulisher
Nov 26, 2025

Verrica Pharmaceuticals Insider Bought Shares Worth $17,505,157, According to a Recent SEC Filing - MarketScreener

Nov 26, 2025
pulisher
Nov 25, 2025

Verrica Pharmaceuticals announces $50M PIPE financing - MSN

Nov 25, 2025
pulisher
Nov 25, 2025

Insider Buying: John Kirby Acquires Shares of Verrica Pharmaceuticals Inc (VRCA) - GuruFocus

Nov 25, 2025
pulisher
Nov 25, 2025

Caligan Partners LP Significantly Increases Stake in Verrica Pharmaceuticals Inc - GuruFocus

Nov 25, 2025
pulisher
Nov 24, 2025

Verrica arranges $50M financing to pay off debt, pursue 'billion-dollar market opportunities' - The Business Journals

Nov 24, 2025
pulisher
Nov 24, 2025

Watkins Advises on Verrica Pharmaceuticals’ US$50 Million Private Placement Financing - Latham & Watkins LLP

Nov 24, 2025
pulisher
Nov 24, 2025

Is Verrica Pharmaceuticals Inc 1NE a good long term investmentPrice Channel Trading & Free Phenomenal Capital Appreciation - earlytimes.in

Nov 24, 2025
pulisher
Nov 24, 2025

Verrica Pharmaceuticals Announces Financing of $50 Million - citybiz

Nov 24, 2025
pulisher
Nov 24, 2025

Verrica Pharmaceuticals Secures $50M Financing Deal - TipRanks

Nov 24, 2025
pulisher
Nov 24, 2025

Verrica Pharmaceuticals stock jumps after $50M financing deal By Investing.com - Investing.com Nigeria

Nov 24, 2025
pulisher
Nov 24, 2025

Verrica Pharmaceuticals stock jumps after $50M financing deal - Investing.com India

Nov 24, 2025
pulisher
Nov 24, 2025

Verrica Pharmaceuticals (VRCA) Secures $50 Million Through PIPE Deal - GuruFocus

Nov 24, 2025
pulisher
Nov 24, 2025

Verrica Pharmaceuticals announces private placement financing of $50 million - TradingView

Nov 24, 2025
pulisher
Nov 24, 2025

Verrica Pharmaceuticals (VRCA) Secures $50 Million Through PIPE Financing - GuruFocus

Nov 24, 2025
pulisher
Nov 24, 2025

[8-K] Verrica Pharmaceuticals Inc. Reports Material Event | VRCA SEC FilingForm 8-K - Stock Titan

Nov 24, 2025
pulisher
Nov 24, 2025

Verrica raises $50 million to repay debt, extend cash runway - Investing.com

Nov 24, 2025
pulisher
Nov 24, 2025

Verrica Pharmaceuticals Announces Private Placement Financing of $50 Million to Retire Debt and ... - Enidnews.com

Nov 24, 2025
pulisher
Nov 24, 2025

Verrica (NASDAQ: VRCA) Announces $50M PIPE to Retire OrbiMed Debt, Extend Runway to 2027 - Stock Titan

Nov 24, 2025
pulisher
Nov 22, 2025

Verrica Pharmaceuticals to Present at Needham Healthcare Conference - MSN

Nov 22, 2025
pulisher
Nov 22, 2025

Verrica Pharmaceuticals Inc. announced that it expects to receive $50.067383 million in funding from BKB Growth Investments, LLC and other investors - MarketScreener

Nov 22, 2025
pulisher
Nov 21, 2025

Why Verrica Pharmaceuticals Inc. (1NE) stock is a must watch tickerWeekly Gains Report & Risk Adjusted Buy/Sell Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Will Verrica Pharmaceuticals Inc. stock maintain growth storyJuly 2025 Breakouts & Expert Approved Momentum Trade Ideas - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

New Cancer Data Hints at a Surgery-Free Future — Verrica’s VP-315 Shows Big Promise - MSN

Nov 20, 2025
pulisher
Nov 20, 2025

Verrica Posts Strong Q3 as YCANTH Momentum Builds and Late-Stage Pipeline Advances - MyChesCo

Nov 20, 2025
pulisher
Nov 20, 2025

Can Verrica Pharmaceuticals Inc. (1NE) stock deliver consistent EPS growthInsider Buying & Long-Term Capital Growth Strategies - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How Verrica Pharmaceuticals Inc. (1NE) stock reacts to stronger dollarGold Moves & Short-Term Swing Trade Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How forex fluctuations impact Verrica Pharmaceuticals Inc. (1NE) stockJuly 2025 Fed Impact & Smart Money Movement Tracker - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

What MACD trends signal for Verrica Pharmaceuticals Inc. (1NE) stockLayoff News & Reliable Breakout Forecasts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Verrica Pharmaceuticals Inc. (1NE) stock a top hedge fund pickJuly 2025 Trends & Weekly Market Pulse Alerts - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Can trapped investors hope for a rebound in Verrica Pharmaceuticals Inc.Portfolio Risk Report & Stepwise Entry and Exit Trade Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What RSI levels show for Verrica Pharmaceuticals Inc. (1NE) stockTake Profit & Consistent Growth Equity Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Verrica Pharmaceuticals Inc. stock a smart buy before Fed meeting2025 Fundamental Recap & Expert Curated Trade Setup Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why analysts raise outlook for Verrica Pharmaceuticals Inc. (1NE) stock - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why retail traders accumulate Verrica Pharmaceuticals Inc. (1NE) stockMarket Performance Summary & Verified Technical Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Verrica Pharmaceuticals Inc. (VRCA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 05:26:49 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Should I buy Verrica Pharmaceuticals Inc. (1NE) stock before earnings seasonDollar Strength & Capital Efficiency Focused Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why analysts recommend Verrica Pharmaceuticals Inc. (1NE) stockLong Setup & Weekly Top Gainers Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What Fibonacci levels say about Verrica Pharmaceuticals Inc. reboundWeekly Gains Report & Precise Swing Trade Alerts - newser.com

Nov 19, 2025

Finanzdaten der Verrica Pharmaceuticals Inc-Aktie (VRCA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$39.84
price up icon 0.76%
$31.92
price up icon 1.66%
$105.65
price up icon 0.09%
$102.70
price up icon 3.00%
biotechnology ONC
$340.64
price up icon 1.63%
$204.51
price down icon 2.16%
Kapitalisierung:     |  Volumen (24h):